mosapride has been researched along with Intestinal Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Amagase, K; Horie, S; Kato, S; Matsuda, N; Matsumoto, K; Onimaru, N; Takeuchi, K; Wada, M; Yasuda, M | 1 |
1 other study(ies) available for mosapride and Intestinal Diseases
| Article | Year |
|---|---|
Dual role of serotonin in the pathogenesis of indomethacin-induced small intestinal ulceration: pro-ulcerogenic action via 5-HT3 receptors and anti-ulcerogenic action via 5-HT4 receptors.
Topics: Aconitine; alpha7 Nicotinic Acetylcholine Receptor; Animals; Anti-Ulcer Agents; Benzamides; Fenclonine; Indoles; Indomethacin; Intestinal Diseases; Intestine, Small; Male; Mice; Mice, Inbred C57BL; Morpholines; Ondansetron; Receptors, Nicotinic; Receptors, Serotonin; Receptors, Serotonin, 5-HT3; Receptors, Serotonin, 5-HT4; Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Sulfonamides; Ulcer | 2012 |